Inventor · disambiguated record
Antje Rottmann
Also filed as: ROTTMANN ANTJE
8 granted patents·11 pending applications·29 citations·filing 2007–2022
83Inventor score
Top patents by PatentIndex Score
19 records- 0190US10202369B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2017·Granted Feb 12, 2019·4 cites·26 claims
- 0289US10472354B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2018·Granted Nov 12, 2019·3 cites·13 claims
- 0389US10174016B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2015·Granted Jan 8, 2019·4 cites·34 claims
- 0486US11142523B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2019·Granted Oct 12, 2021·2 cites·16 claims
- 0582US8053426B2Progesterone receptor antagonistsBAYER SCHERING PHARMA AG·Filed 2007·Granted Nov 8, 2011·12 cites·28 claims
- 0681US10183937B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2017·Granted Jan 22, 2019·4 cites·22 claims
- 0773US2023053411A11,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2021·Application pending·0 cites
- 0856US2025282734A1Cholinate of 2-(1-cyclobutyl-1h-pyrazol-4-yl)-5-[([{1-[2-fluoro-4-(trifluoromethyl)-phenyl]cyclopropyl}carbonyl)amino]benzoic acidBAYER AG·Filed 2022·Application pending·0 cites
- 0953US2024239804A1Furoindazole derivatives as antagonists or inhibitors of gpr84BAYER AG·Filed 2022·Application pending·0 cites
- 1051US2024417407A1Furoindazole derivatives as gpr84 antagonistsBAYER AG·Filed 2022·Application pending·0 cites
- 1148US10894805B2Prodrugs of the selective progesterone receptor modulator (SPRM) (11.beta.,17.beta.)-17-Hydroxy-11-[4-(methylsulphonyl)phenyl] -17-(pentafluoroethyl)estra-4,9-dien-3-oneBayer Pharma AG·Filed 2017·Granted Jan 19, 2021·0 cites·12 claims
- 1248US2023013419A1Analogues of 3-(5-methyl-1,3-thiazol-2-yl)-n-{(1r)-1-[2-(trifluoro-methyl)pyrimidin-5-yl]ethyl}benzamideBAYER AG·Filed 2020·Application pending·0 cites
- 1348US2023072421A1Targeted radiopharmaceuticals for the diagnosis and treatment of prostate cancerBAYER AS·Filed 2020·Application pending·0 cites
- 1442US2020085791A1[(phenylsulfonyl)octahydro-epiminoisoindol-yl](1h-1,2,3-triazol-5-yl)methanonesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 1537US10167293B2[8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanonesBayer Pharma AG·Filed 2017·Granted Jan 1, 2019·0 cites·18 claims
- 1637US2020079758A1[4-(phenylsulfonyl)piperazin-1-yl](1h-1,2,3-triazol-4-yl)methanonesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 1735US2020087284A1[4-(phenylsulfonyl)piperazin-1-yl](1h-1, 2, 3-triazol-4-yl)methanonesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 1833US2017217946A1Amino-substituted isoxazolesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 1932US2017334899A1Amino-substituted isothiazolesBayer Pharma AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Antje Rottmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →